Defective HIV-1 Genomes and Their Potential Impact on HIV Pathogenesis

Overview

Journal Retrovirology

Publisher Biomed Central

Specialty Microbiology

Date 2022 Jun 28

PMID 35764966

Authors

Jeffrey Kuniholm

Carolyn Coote

Andrew J Henderson

Affiliations

Soon will be listed here.

Abstract

Defective HIV-1 proviruses represent a population of viral genomes that are selected for by immune pressures, and clonally expanded to dominate the persistent HIV-1 proviral genome landscape. There are examples of RNA and protein expression from these compromised genomes which are generated by a variety of mechanisms. Despite the evidence that these proviruses are transcribed and translated, their role in HIV pathogenesis has not been fully explored. The potential for these genomes to participate in immune stimulation is particularly relevant considering the accumulation of cells harboring these defective proviruses over the course of antiretroviral therapy in people living with HIV. The expression of defective proviruses in different cells and tissues could drive innate sensing mechanisms and inflammation. They may also alter antiviral T cell responses and myeloid cell functions that directly contribute to HIV-1 associated chronic comorbidities. Understanding the impact of these defective proviruses needs to be considered as we advance cure strategies that focus on targeting the diverse population of HIV-1 proviral genomes.

Citing Articles

Antivirotics based on defective interfering particles: emerging concepts and challenges.

Maryanchik S, Borovikova S, Ivanova A, Trofimov V, Bagrova O, Frolova A Front Cell Infect Microbiol. 2025; 15:1436026.

PMID: 40066067 PMC: 11891348. DOI: 10.3389/fcimb.2025.1436026.

Immune Alterations and Viral Reservoir Atlas in SIV-Infected Chinese Rhesus Macaques.

Clain J, Picard M, Rabezanahary H, Andre S, Boutrais S, Goma Matsetse E Infect Dis Rep. 2025; 17(1).

PMID: 39997464 PMC: 11855486. DOI: 10.3390/idr17010012.

Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places.

Chen W, Berkhout B, Pasternak A Curr HIV/AIDS Rep. 2025; 22(1):15.

PMID: 39903363 PMC: 11794352. DOI: 10.1007/s11904-025-00723-6.

Magnetoelectric Extracellular Vesicle Latency-Targeting (MELT) Nanotherapeutic for the Block-Lock-and-Kill HIV Eradication Strategy.

Andre M, Kolishetti N, Yndart A, Vashist A, Nair M, Raymond A Biomedicines. 2025; 13(1).

PMID: 39857731 PMC: 11762476. DOI: 10.3390/biomedicines13010147.

Defective proviruses significantly impact viral transcription and immune activation in men and women with HIV-1 subtype C in rural South Africa.

Buchholtz N, Hermans L, Umunnakwe C, Nuhn M, Voss R, Need E Front Immunol. 2024; 15:1484358.

PMID: 39660138 PMC: 11628515. DOI: 10.3389/fimmu.2024.1484358.

References

Hoffmann M, Pantazis N, Martin G, Hickling S, Hurst J, Meyerowitz J . Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection. PLoS Pathog. 2016; 12(7):e1005661. PMC: 4945085. DOI: 10.1371/journal.ppat.1005661. View

Horvath S, Levine A . HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015; 212(10):1563-73. PMC: 4621253. DOI: 10.1093/infdis/jiv277. View

Atkins A, Allen A, Dampier W, Haddad E, Nonnemacher M, Wigdahl B . HIV-1 cure strategies: why CRISPR?. Expert Opin Biol Ther. 2020; 21(6):781-793. PMC: 9777058. DOI: 10.1080/14712598.2021.1865302. View

Meas H, Haug M, Beckwith M, Louet C, Ryan L, Hu Z . Sensing of HIV-1 by TLR8 activates human T cells and reverses latency. Nat Commun. 2020; 11(1):147. PMC: 6952430. DOI: 10.1038/s41467-019-13837-4. View

Antar A, Jenike K, Jang S, Rigau D, Reeves D, Hoh R . Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy. J Clin Invest. 2020; 130(7):3543-3559. PMC: 7324206. DOI: 10.1172/JCI135953. View

Calain P, Roux L, Kolakofsky D . Defective interfering genomes and Ebola virus persistence. Lancet. 2016; 388(10045):659-60. DOI: 10.1016/S0140-6736(16)31272-7. View

Manzoni T, Lopez C . Defective (interfering) viral genomes re-explored: impact on antiviral immunity and virus persistence. Future Virol. 2018; 13(7):493-503. PMC: 6136085. DOI: 10.2217/fvl-2018-0021. View

Sankaran S, George M, Reay E, Guadalupe M, Flamm J, Prindiville T . Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol. 2007; 82(1):538-45. PMC: 2224350. DOI: 10.1128/JVI.01449-07. View

Pollack R, Jones R, Pertea M, Bruner K, Martin A, Thomas A . Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. Cell Host Microbe. 2017; 21(4):494-506.e4. PMC: 5433942. DOI: 10.1016/j.chom.2017.03.008. View

10.

Dutilleul A, Rodari A, Van Lint C . Depicting HIV-1 Transcriptional Mechanisms: A Summary of What We Know. Viruses. 2020; 12(12). PMC: 7761857. DOI: 10.3390/v12121385. View

11.

Abrahams M, Joseph S, Garrett N, Tyers L, Moeser M, Archin N . The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation. Sci Transl Med. 2019; 11(513). PMC: 7233356. DOI: 10.1126/scitranslmed.aaw5589. View

12.

Cohn L, Silva I, Oliveira T, Rosales R, Parrish E, Learn G . HIV-1 integration landscape during latent and active infection. Cell. 2015; 160(3):420-32. PMC: 4371550. DOI: 10.1016/j.cell.2015.01.020. View

13.

Affram Y, Zapata J, Gholizadeh Z, Tolbert W, Zhou W, Iglesias-Ussel M . The HIV-1 Antisense Protein ASP Is a Transmembrane Protein of the Cell Surface and an Integral Protein of the Viral Envelope. J Virol. 2019; 93(21). PMC: 6803264. DOI: 10.1128/JVI.00574-19. View

14.

Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A . Perturbed CD8 T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017; 7:40354. PMC: 5233961. DOI: 10.1038/srep40354. View

15.

Wiegand A, Spindler J, Hong F, Shao W, Cyktor J, Cillo A . Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART. Proc Natl Acad Sci U S A. 2017; 114(18):E3659-E3668. PMC: 5422779. DOI: 10.1073/pnas.1617961114. View

16.

Preston B, Poiesz B, Loeb L . Fidelity of HIV-1 reverse transcriptase. Science. 1988; 242(4882):1168-71. DOI: 10.1126/science.2460924. View

17.

Olson A, Coote C, Snyder-Cappione J, Lin N, Sagar M . HIV-1 Transcription but Not Intact Provirus Levels are Associated With Systemic Inflammation. J Infect Dis. 2020; 223(11):1934-1942. PMC: 8176637. DOI: 10.1093/infdis/jiaa657. View

18.

Morris A, Marsden M, Halcrow K, Hughes E, Brettle R, Bell J . Mosaic structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations. J Virol. 1999; 73(10):8720-31. PMC: 112893. DOI: 10.1128/JVI.73.10.8720-8731.1999. View

19.

Imamichi H, Dewar R, Adelsberger J, Rehm C, ODoherty U, Paxinos E . Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy. Proc Natl Acad Sci U S A. 2016; 113(31):8783-8. PMC: 4978246. DOI: 10.1073/pnas.1609057113. View

20.

Harris R, Bishop K, Sheehy A, Craig H, Petersen-Mahrt S, Watt I . DNA deamination mediates innate immunity to retroviral infection. Cell. 2003; 113(6):803-9. DOI: 10.1016/s0092-8674(03)00423-9. View